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Bacterial meningitis is a severe illness with potentially
dangerous consequences in any patient population. In the years
from 2003 to 2007, children less than two years old had the highest
estimated rate of bacterial meningitis of any age group. [1] In
neonates, not only are the risks of infection profound – including
death – the presentation can be atypical, making the likelihood of
occult disease all the greater. [2] Unlike older children and adults
with meningitis, neonates typically do not present with veriﬁable
meningismus. [3,4] Irritability is a common presenting symptom
but it is non-speciﬁc [4]. The fact that undiagnosed meningitis is
the most common source of medical malpractice claims in
pediatric emergency rooms underscores the high requirement
for astute and accurate clinical care. [5] Fortunately bacterial
meningitis is relatively uncommon, with a rate of 80.69 cases per
100,000 in infants less than 2 months of age in one study [1].
Case
A 31-day-old, previously healthy term infant was transferred
from an outside hospital for management of meningitis. One day
prior to admission she developed low-grade fever, emesis, loose
stools, decreased urine output, and subjective fussiness. Her past
medical history was signiﬁcant only for a murmur noted at birth
with a normal echocardiogram. She had no signiﬁcant travel
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celebration. She had been evaluated at a local urgent care prior to
admission and diagnosed with a viral respiratory tract infection.
Her fevers continued prompting evaluation at a local emergency
department. On exam, she was febrile with a bulging fontanel,
irritable, and pale. She underwent a diagnostic evaluation
including lumbar puncture. Her cerebral spinal ﬂuid (CSF) had
2875 white blood cells/mm3 with neutrophil predominance,
hypoglycorrhaia (glucose 2 mg/dL), elevated protein (>150 mg/
dL) and gram negative diplococci on gram stain. Lab values were
signiﬁcant for leukopenia with a white blood cell count (WBC) of
2500/mm3 (with an absolute neutrophil count of 1050/mm3), an
elevated C reactive protein (5.9 mg/dL), and elevated procalcitonin
(14.72 ng/mL). She was treated empirically with intravenous (IV)
ampicillin, cefotaxime, and vancomycin prior to transfer.
The patient was continued on IV vancomycin and cefotaxime
upon admission to the receiving institution. Based upon the initial
reported gram stain, the causative agent was thought to be
Neisseria meningitidis. On the morning of hospital day 2, the initial
CSF and blood cultures performed at the outside hospital were
reported growing a presumptive b-lactamase-negative Haemo-
philus species. The cultures were transferred to the State Hygienic
Facility for conﬁrmatory speciation. As the culture medium was
standard blood agar, the State Hygienic Facility felt Haemophilus
was unlikely.
On hospital day 3, the State Hygienic Facility reported that the
organism was not a Haemophilus species but rather Pasteurella
multocida. Upon further questioning, it was learned that the family
had 2 cats and a dog. The dog had been observed licking the infant’s
face. Based on antimicrobial susceptibilities, vancomycin was
discontinued and she continued on cefotaxime monotherapy at
meningitic dosing. Despite clinical improvement and appropriate
antimicrobial treatment, she remained febrile until hospital day 6.
No subdural or parenchymal abscess was seen on brain magnetic
resonance imaging (MRI) performed on hospital day 4.-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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900/mm3) and was found to have a peripheral inserted central
venous catheter (PICC) line associated thrombosis. The PICC line
was removed with resolution of her leukocytosis. She completed
2 weeks of IV cefotaxime to treat her acute bacterial meningitis
from Pasteurella multocida. The infection was thought to have been
transmitted to the infant via saliva from the family dog. At
discharge, she was clinically well and had a normal physical exam.
Discussion
The epidemiology of bacterial meningitis in infants differs
based on age and is often classiﬁed as infection originating either
within or beyond the neonatal period. During the neonatal period,
group B streptococcus (GBS) and Escherichia coli, are the most
common bacteria that cause meningitis. Historically, Listeria
monocytogenes was a more common cause of neonatal and
infantile serious bacterial infections including meningitis. A recent
meta-analysis reported L. monocytogenes bacteremia and menin-
gitis in febrile infants to be very uncommon with reported
prevalences of 0.03% and 0.09%, respectively. [6] Additional studies
have reported similar ﬁndings, and have challenged the continued
use of ampicillin in empiric treatment of febrile infants. [6–8]
Beyond the neonatal period, Streptococcus pneumoniae and
Neisseria meningitidis become common pathogens. [9] Prior to
the era of conjugate vaccination, Haemophilus inﬂuenzae type b
(Hib) was the most common cause of meningitis in infants, and
should still be considered in the differential, especially in an
unimmunized or immunodeﬁcient infant or child. [10] Rapid
pathogen identiﬁcation is important to determine optimal therapy
and the need for post-exposure prophylaxis of contacts which may
be warranted in the case of meningitis caused by Neisseria
meningitidis and Hib.
In this case, the organism was identiﬁed as Pasteurella
multocida, a gram-negative coccobacillus that often colonizes
the oral cavity of animals, including pets and livestock such as
dogs, cats, rabbits, hogs, and deer. [11,12] It is an uncommon cause
of meningitis. As per McKelvie in 2013, a total of 38 cases of P.
multocida meningitis in infants had been reported in the English
literature. [11] The age was known in 36 cases with 30 infants
3 months of age and of those 18 were under 1 month of age. [11]
Non-traumatic source of infection, including meningitis in infants
after exposure to animal saliva, has been well described in the
literature. [12] Traumatic exposure (bites or scratches) is rare with
most meningeal infections resulting from salvia exposure via
licking or snifﬁng by a dog or cat. [2,11,13] Alternatively, exposure
may be indirect from being handled by someone who didn’t wash
their hands after contact with a pet or via contaminated fomites as
in the case of an infant who likely acquired her meningeal infection
when the infant used her paciﬁer after the family cat had licked it.
[2,11]
Because Pasteurella is a rare cause of meningitis, it can be
confused initially with other pathogens such as Haemophilus or
Neisseria, especially when a gram negative coccobacillus is seen on
gram stain as in this case. [11,14] Biochemical testing and
assessment of growth characteristics on various media can assist
with the diagnosis, particularly when including such an organism
as Pasteurella in the differential diagnosis. Attempted growth on
blood agar and chocolate agar will show robust growth, in contrast
to the factor V- and X-requiring Haemophilus species which will not
grow on standard blood agar. Indole testing can assist with
distinguishing it from Neisseria and Haemophilus species as
Pasteurella is typically indole positive while the latter are not.
[11,15]
P. multocida is typically susceptible to penicillin and other
commonly used antimicrobials including the later generationcephalosporins, ceftriaxone, and ceﬁxime. [2,11,16] Cephalexin and
clindamycin are known to be ineffective against the organism.
[17,18] Documentation of acquired resistance has been limited, but
includes report of strains producing a b-lactamase. [19] Most
infants treated with appropriate antimicrobial therapy recover
completely without sequelae. [2,11]
Conclusions
Determining the causative organism in this infant with
meningitis proved to be difﬁcult. Correct identiﬁcation required
astute microbiology laboratory practices and a keen clinical eye to
carefully evaluate all exposures. This case underscores the need to
assess for exposure to pets, in addition to sick contacts, and the
importance of educating parents and caretakers on the risks
associated with exposures to such animals. It would be wise to
advise caretakers to not let animals lick infants and to wash hands
after animal contact.
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